FDA Safety Measures May not Reduce Death from Pain Killers

Authors

Adam M. Kaye, University of the PacificFollow

ORCiD

Adam M. Kaye: 0000-0002-7224-3322

Document Type

Blog Post

Publication Title

RxEconsult, LLC

Publication Date

7-16-2012

Abstract

The U.S. Food and Drug Administration today approved a risk evaluation and mitigation strategy (REMS) for extended-release (ER) and long-acting (LA) prescription pain killers (opioids), highly potent drugs approved for moderate to severe, persistent pain that requires treatment for an extended period.

Recommended Citation

Kaye, A. M. (2012). FDA Safety Measures May not Reduce Death from Pain Killers. RxEconsult, LLC, ,
https://scholarlycommons.pacific.edu/phs-facarticles/649